Unknown

Dataset Information

0

Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor.


ABSTRACT:

Aims

The endothelium has emerged recently as a therapeutic target in the treatment of hypertension because endothelial dysfunction and subsequent vascular rarefaction cause target organ damage and further elevate blood pressure (BP). It led us to hypothesize that one of the endothelial survival factors, a potent derivative of angiopoietin-1 (cartilage oligomeric matrix protein, COMP-Ang-1), could be a novel class of antihypertensive agents that maintain endothelial integrity and function, thereby preventing the development of hypertension and target organ damage.

Methods and results

To study the role of COMP-Ang-1 in preventing hypertension and target organ damage, a COMP-Ang-1 plasmid was electroporated into adductor muscles of 6 weeks old, pre-hypertensive, spontaneously hypertensive rats (SHRs), and the secretion of its expressed protein into the bloodstream was confirmed by western blotting. In comparison with sham and reporter gene transfer, COMP-Ang-1 gene transfer significantly prevented increases in systolic BP and reduced microvascular rarefaction and tissue damage in the heart and kidney. However, overexpression of soluble Tie2 receptor completely abolished these beneficial effects of COMP-Ang-1 gene transfer on SHRs, indicating that expressed COMP-Ang-1 protein has antihypertensive effects in SHRs by binding Tie2 receptors on the vascular endothelium. In particular, COMP-Ang-1 gene-transferred SHRs had significantly higher plasma levels of nitrite than other controls, which was found to be due to that expressed COMP-Ang-1 protein promoted nitrite synthesis by activating endothelial nitric oxide synthase, one of the Tie2 downstream-signalling molecules.

Conclusion

The present study suggests a new potential of endothelial survival factor, COMP-Ang-1, as an antihypertensive agent that effectively reduces the hypertension-associated cardiovascular and renal damage, as well as prevents the further elevation of BP.

SUBMITTER: Lee JS 

PROVIDER: S-EPMC5436684 | biostudies-literature | 2008 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor.

Lee Jung-Sun JS   Song Sun-Hwa SH   Kim Jeong-Min JM   Shin In-Soon IS   Kim Koung Li KL   Suh Yeon-Lim YL   Kim Hak-Zoo HZ   Koh Gou Young GY   Byun Jonghoe J   Jeon Eun-Seok ES   Suh Wonhee W   Kim Duk-Kyung DK  

Cardiovascular research 20080219 3


<h4>Aims</h4>The endothelium has emerged recently as a therapeutic target in the treatment of hypertension because endothelial dysfunction and subsequent vascular rarefaction cause target organ damage and further elevate blood pressure (BP). It led us to hypothesize that one of the endothelial survival factors, a potent derivative of angiopoietin-1 (cartilage oligomeric matrix protein, COMP-Ang-1), could be a novel class of antihypertensive agents that maintain endothelial integrity and function  ...[more]

Similar Datasets

| S-EPMC6348720 | biostudies-literature
| S-EPMC218758 | biostudies-literature
| S-EPMC3253170 | biostudies-other
| S-EPMC3366398 | biostudies-literature
| S-EPMC8571544 | biostudies-literature
| S-EPMC5523792 | biostudies-literature
| S-EPMC3404972 | biostudies-literature